Skip to Main Content

Author Details

Gillian C Bell
Mission Health Personalized Medicine & Pharmacogenomics Program
2011
23
13
PMIDPaper TitleJournal TitlePublished Year
37032427Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants.Clin Pharmacol Ther2023
35876085A clinician's guide for counseling patients on results of a multigene pharmacogenomic panel.Am J Health Syst Pharm2022
33448876North Carolina's multi-institutional pharmacogenomics efforts with the North Carolina Precision Health Collaborative.Pharmacogenomics2021
33461326Synthesis of major pharmacogenomics pretest counseling themes: a multisite comparison.Pharmacogenomics2021
32308829Development of a Genomic Data Flow Framework: Results of a Survey Administered to NIH-NHGRI IGNITE and eMERGE Consortia Participants.AMIA Annu Symp Proc2020
31109249Implementing a personalized medicine cancer program in a community cancer system.Per Med2019
30983513Implementing pharmacogenetic testing in rural primary care practices: a pilot feasibility study.Pharmacogenomics2019
29546524Prediction of chemotherapy-induced nausea and vomiting from patient-reported and genetic risk factors.Support Care Cancer2018
30345883Implementing a personalized medicine program in a community health system.Pharmacogenomics2018
28002639Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 genotype and use of ondansetron and tropisetron.Clin Pharmacol Ther2017
28179575Key Lessons Learned from Moffitt's Molecular Tumor Board: The Clinical Genomics Action Committee Experience.Oncologist2017
28699700Pharmacogenomics Implementation: Considerations for Selecting a Reference Laboratory.Pharmacotherapy2017
28549953Incidence and Triggers of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in a Large Cancer Patient Cohort.J Invest Dermatol2017
27864203Implementation of a multidisciplinary pharmacogenomics clinic in a community health system.Am J Health Syst Pharm2016
26479518Pharmacogenetic allele nomenclature: International workgroup recommendations for test result reporting.Clin Pharmacol Ther2016
26233624Budget impact analysis of CYP2C19-guided voriconazole prophylaxis in AML.J Antimicrob Chemother2015
26678969Clinical Implications of Opioid Pharmacogenomics in Patients With Cancer.Cancer Control2015
26716078Detection of a PDGFRB fusion in refractory CMML without eosinophilia: A case for broad spectrum tumor profiling.Leuk Res Rep2015
23978487Development and use of active clinical decision support for preemptive pharmacogenomics.J Am Med Inform Assoc2014
27202188Budget Impact Analysis of CYP2C19 Genotyping to Target Voriconazole Prophylaxis During Induction-Consolidation Therapy in Acute Myeloid Leukemia (AML) in The United States.Value Health2014
23588301The Pharmacogenomics Research Network Translational Pharmacogenetics Program: overcoming challenges of real-world implementation.Clin Pharmacol Ther2013
212478372010 pertussis outbreak and updated Tdap recommendations.J Am Pharm Assoc (2003)2011
22345720Faculty and student perceptions of effective study strategies and materials.Am J Pharm Educ2011
  • 1 - 23 of 23

Recommended Authors

Department of Pharmacotherapy and Translational Research, University of Florida
Career Start Year 2019
Number of shared co-authors 9
Massachusetts General Hospital
Career Start Year 2018
Number of shared co-authors 2
Center for Individualized Medicine, College of Medicine, Mayo Clinic
Career Start Year 2014
Number of shared co-authors 11
Indiana University School of Medicine
Career Start Year 2014
Number of shared co-authors 9
Center for Individualized Medicine, Mayo Clinic
Career Start Year 2013
Number of shared co-authors 5
VA Salt Lake City Healthcare System (VINCI)
Career Start Year 2013
Number of shared co-authors 2
HealthPartners Institute
Career Start Year 2011
Number of shared co-authors 0
European Bioinformatics Institute (EMBL-EBI)
Career Start Year 2008
Number of shared co-authors 16
Vanderbilt University Medical Center
Career Start Year 2007
Number of shared co-authors 15
Georgetown University Medical Center
Career Start Year 2006
Number of shared co-authors 29
Yale School of Medicine
Career Start Year 2005
Number of shared co-authors 2
Harvard Medical School and the Harvard Pilgrim Health Care Institute
Career Start Year 2004
Number of shared co-authors 0
Feinberg School of Medicine, Northwestern University
Career Start Year 2003
Number of shared co-authors 0
Institute for Genomic Health, Icahn School of Medicine at Mount Sinai
Career Start Year 2002
Number of shared co-authors 16
National Institutes of Health
Career Start Year 2002
Number of shared co-authors 28
12328Vanderbilt University Medical Center
Career Start Year 2001
Number of shared co-authors 4
Institute for Public Health Genetics, University of Washington
Career Start Year 2000
Number of shared co-authors 10
Department of Pharmacotherapy & Translational Research, University of Florida
Career Start Year 1999
Number of shared co-authors 46
Mayo Clinic
Career Start Year 1999
Number of shared co-authors 12
Duke University School of Medicine
Career Start Year 1999
Number of shared co-authors 7
Yale School of Medicine
Career Start Year 1999
Number of shared co-authors 7
Vanderbilt University Medical Center
Career Start Year 1997
Number of shared co-authors 12
University of Pennsylvania Perelman School of Medicine
Career Start Year 1996
Number of shared co-authors 20
Department of Pharmacy, Boston Children's Hospital
Career Start Year 1996
Number of shared co-authors 12
University of Washington
Career Start Year 1992
Number of shared co-authors 16
BC Children's Hospital Research Institute
Career Start Year 1991
Number of shared co-authors 5
Deverka Consulting LLC
Career Start Year 1991
Number of shared co-authors 11
University of North Carolina at Chapel Hill
Career Start Year 1987
Number of shared co-authors 34
University of Washington Medical Center
Career Start Year 1985
Number of shared co-authors 38
National Institutes of Health
Career Start Year 1981
Number of shared co-authors 20

Collaborators

H. Lee Moffitt Cancer Center and Research Institute
Co-authored papers 7
Center for Precision Medicine and Functional Genomics, Utah Tech University
Co-authored papers 7
Stanford University
Co-authored papers 4
Duke University Research Institute
Co-authored papers 3
Stanford University
Co-authored papers 3
Center for Individualized Medicine, Mayo Clinic
Co-authored papers 3
Departments of Pharmaceutical Sciences.
Co-authored papers 3
Vanderbilt University Medical Center
Co-authored papers 2
University of Tennessee Health Science Center
Co-authored papers 2
Stanford University
Co-authored papers 2
and of Biochemistry and Pharmacy, University of Tuebingen
Co-authored papers 2
Icahn School of Medicine at Mount Sinai
Co-authored papers 2
St. Jude Children's Research Hospital Memphis
Co-authored papers 2
Departments of Oncology. St. Jude Children's Research Hospital
Co-authored papers 2
Medical College of Wisconsin
Co-authored papers 2
College of Nursing
Co-authored papers 2
Department of Pharmacotherapy and Translational Research, University of Florida
Co-authored papers 2
St. Jude Children's Research Hospital
Co-authored papers 2
St. Jude Children's Research Hospital
Co-authored papers 2
St. Jude Children's Research Hospital
Co-authored papers 2
University of Maryland
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Greenebaum Comprehensive Cancer Center, University of Maryland
Co-authored papers 1
Cincinnati Children's Hospital Medical Center
Co-authored papers 1
Vanderbilt University Medical Center
Co-authored papers 1
Vanderbilt University Medical Center.
Co-authored papers 1
Oak Ridge National Laboratory
Co-authored papers 1
Neaman Center for Personalized Medicine, NorthShore University HealthSystem
Co-authored papers 1
University of Maryland
Co-authored papers 1